v3.26.1
Equity Method Investment (Tables)
6 Months Ended
Jun. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investment

The following summarizes the Company’ consolidated balance sheet equity method investment as follows (in thousands):

 

   Carrying Amount 
December 31, 2025, beginning balance  $37,543 
Portion of loss from eXoZymes   (2,409)
Impairment of equity investment   (641)
Loss related to dilution events   (1,363)
Rounding   (1)
June 30, 2026, carrying amount  $33,129